Arlo Technologies, Inc. Launches Roadshow for Initial Public Offering
/
Date25 Jul 2018
SAN JOSE, Calif., July 23, 2018 (GLOBE NEWSWIRE) — NETGEAR®, Inc. (NASDAQ:NTGR), the worldwide leader in home networking and smart home security products, today announced... Read More →
Establishment Labs Announces Closing of Initial Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Common Shares
/
Date24 Jul 2018
NEW YORK, July 23, 2018 (GLOBE NEWSWIRE) — Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies,... Read More →
Rubius Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
/
Date23 Jul 2018
CAMBRIDGE, Mass., July 23, 2018 (GLOBE NEWSWIRE) — Rubius Therapeutics, Inc. (Nasdaq:RUBY), a biotechnology company pioneering the development of a new class of ready-to-use cellular... Read More →
First Western Financial, Inc. Announces Pricing of Initial Public Offering
/
Date22 Jul 2018
DENVER, July 18, 2018 (GLOBE NEWSWIRE) — First Western Financial, Inc., a financial holding company headquartered in Denver, Colorado (“First Western”), announced today the pricing... Read More →
Establishment Labs Announces Pricing of Initial Public Offering
/
Date21 Jul 2018
NEW YORK, July 18, 2018 (GLOBE NEWSWIRE) — Establishment Labs Holdings Inc. (NASDAQ:ESTA), a global medical technology company focused on breast aesthetics and reconstruction technologies,... Read More →
Replimune Announces Pricing of Initial Public Offering
/
Date20 Jul 2018
WOBURN, Mass., July 19, 2018 (GLOBE NEWSWIRE) — Replimune Group, Inc., a biotechnology company developing oncolytic immunotherapies derived from its Immulytic™ platform, today announced the... Read More →
Allakos Announces Pricing of Initial Public Offering
/
Date19 Jul 2018
SAN CARLOS, Calif., July 19, 2018 (GLOBE NEWSWIRE) — Allakos Inc., (Nasdaq:ALLK), a clinical stage biotechnology company focused on the development of antibodies for the... Read More →
Crinetics Pharmaceuticals Announces Pricing of Initial Public Offering
/
Date18 Jul 2018
SAN DIEGO, July 17, 2018 (GLOBE NEWSWIRE) — Crinetics Pharmaceuticals, Inc. (Nasdaq:CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of... Read More →
electroCore, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares in Initial Public Offering
/
Date16 Jul 2018
BASKING RIDGE, N.J., June 28, 2018 (GLOBE NEWSWIRE) — electroCore, Inc. (“electroCore”) (Nasdaq:ECOR) today announced that the underwriters of its previously announced initial public offering... Read More →
Uxin Limited anuncia determinação de preços da oferta pública inicial
/
Date15 Jul 2018
BEIJING, June 28, 2018 (GLOBE NEWSWIRE) — A Uxin Limited (“Uxin” ou a “Empresa”), maior plataforma de comércio eletrônico de carros usados da China, anunciou... Read More →